Updates on the clinical evidenced herb-warfarin interactions

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Ge, Beikang ^a   Zhang, Zhen ^a   Zuo, Zhong ^a  

^a Prince of Wales Hospital   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; CHAMOMILE; HERBACEOUS AGENT; WARFARIN;

ANGELICA DAHURICA; BLEEDING; CACAO; CRANBERRY; DRUG EFFECT; ECHINACEA; EVIDENCE BASED MEDICINE; FENUGREEK; GARLIC; GINGER; GINKGO BILOBA; GINSENG; GRAPEFRUIT; HARPAGOPHYTUM; HERB; HUMAN; HYPERICUM PERFORATUM; INTERNATIONAL NORMALIZED RATIO; LYCIUM; MELILOTUS OFFICINALIS; NONHUMAN; PARSLEY; PEUMUS BOLDUS; PRIORITY JOURNAL; RED CLOVER; REVIEW; SABAL; SALVIA MILTIORRHIZA; SOYBEAN; SQUASH; SWERTIA CHIRAYITA; SYSTEMATIC REVIEW; TEA;

EID: 84897535256     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/957362     Document Type: Review

References (171)

1. Wardrop D., Keeling D., The story of the discovery of heparin and warfarin. British Journal of Haematology 2008 141 6 757 763 2-s2.0-44249090265 10.1111/j.1365-2141.2008.07119.x (Pubitemid 351724858)
2. Horton J. D., Bushwick B. M., Warfarin therapy: evolving strategies in anticoagulation. American Family Physician 1999 59 3 635 646 2-s2.0-0033082809 (Pubitemid 29081325)
3. Wadelius M., Chen L. Y., Downes K., Ghori J., Hunt S., Eriksson N., Wallerman O., Melhus H., Wadelius C., Bentley D., Deloukas P., Common VKORC1 and GGCX polymorphisms associated with warfarin dose. Pharmacogenomics Journal 2005 5 4 262 270 2-s2.0-23644437525 10.1038/sj.tpj.6500313 (Pubitemid 41131718)
4. Vieira M. L. T., Huang S., Botanical-drug interactions: a scientific perspective. Planta Medica 2012 78 1400 1415
5. Tsai H. H., Lin H. W., Lu Y. H., Chen Y. L., Mahady G. B., A review of potential harmful interactions between anticoagulant/antiplatelet agents and Chinese Herbal Medicines. PLoS ONE 2013 8 5 e64255
6. Gohil K. J., Patel J. A., Herb-drug interactions: a review and study based on assessment of clinical case reports in literature. Indian Journal of Pharmacology 2007 39 3 129 139 2-s2.0-34447629547 (Pubitemid 47094666)
7. Izzo A. A., Interactions between herbs and conventional drugs: overview of the clinical data. Medical Principles and Practice 2012 21 404 428 2-s2.0-84855604891 10.1159/000334488
8. Pal D., Mitra A. K., MDR- and CYP3A4-mediated drug-herbal interactions. Life Sciences 2006 78 18 2131 2145 2-s2.0-33644891064 10.1016/j.lfs.2005.12.010
9. Izzo A. A., Herb-drug interactions: an overview of the clinical evidence. Fundamental and Clinical Pharmacology 2005 19 1 1 16 2-s2.0-13444282206 10.1111/j.1472-8206.2004.00301.x (Pubitemid 40204343)
10. de Smet P. A. G. M., Clinical risk management of herb-drug interactions. British Journal of Clinical Pharmacology 2007 63 3 258 267 2-s2.0-33846991638 10.1111/j.1365-2125.2006.02797.x
11. Izzo A. A., di Carlo G., Borrelli F., Ernst E., Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction. International Journal of Cardiology 2005 98 1 1 14 2-s2.0-12844258387 10.1016/j.ijcard.2003.06.039 (Pubitemid 40169845)
12. Patel J. A., Gohil K. J., Warfarin-herb interactions: a review and study based on assessment of clinical case reports in literature. Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas 2008 7 2 85 99 2-s2.0-77955535444
13. Friedman L. M., Furberg C. D., deMets D. L., Fundamentals of Clinical Trials 2010 4th New York, NY, USA Springer
14. Holbrook A. M., Pereira J. A., Labiris R., McDonald H., Douketis J. D., Crowther M., Wells P. S., Systematic overview of warfarin and its drug and food interactions. Archives of Internal Medicine 2005 165 10 1095 1106 2-s2.0-19344366484 10.1001/archinte.165.10.1095 (Pubitemid 40720733)
15. Beyth R. J., Quinn L. M., Landefeld C. S., Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. American Journal of Medicine 1998 105 2 91 99 2-s2.0-0032144231 10.1016/S0002-9343(98)00198-3 (Pubitemid 28405230)
16. Wells P. S., Holbrook A. M., Crowther N. R., Hirsh J., Interactions of warfarin with drugs and food. Annals of Internal Medicine 1994 121 9 676 683 2-s2.0-0028576943
17. O'Reilly R. A., Nelson E., Levy G., Physicochemical and physiologic factors affecting the absorption of warfarin in man. Journal of Pharmaceutical Sciences 1966 55 4 435 437 2-s2.0-0013895445
18. Nutescu E. A., Shapiro N. L., Ibrahim S., West P., Warfarin and its interactions with foods, herbs and other dietary supplements. Expert Opinion on Drug Safety 2006 5 3 433 451 2-s2.0-33646567130 10.1517/14740338.5.3.433
19. Colalto C., Herbal interactions on absorption of drugs: mechanisms of action and clinical risk assessment. Pharmacological Research 2010 62 3 207 227 2-s2.0-77954144994 10.1016/j.phrs.2010.04.001
20. Kaminsky L. S., Zhang Z.-Y., Human P450 metabolism of warfarin. Pharmacology and Therapeutics 1997 73 1 67 74 2-s2.0-0031015345 10.1016/S0163-7258(96)00140-4 (Pubitemid 26425815)
21. Greenblatt D. J., von Moltke L. L., Interaction of warfarin with drugs, natural substances, and foods. Journal of Clinical Pharmacology 2005 45 2 127 132 2-s2.0-16844373618 10.1177/0091270004271404 (Pubitemid 40490435)
22. Harder S., Thürmann P., Clinically important drug interactions with anticoagulants: an update. Clinical Pharmacokinetics 1996 30 6 416 444 2-s2.0-0029886356
23. Sellers E. M., Plasma protein displacement interactions are rarely of clinical significance. Pharmacology 1979 18 5 225 227 2-s2.0-0018363645 (Pubitemid 9206437)
24. Bone K. M., Potential interaction of Ginkgo biloba leaf with antiplatelet or anticoagulant drugs: what is the evidence? Molecular Nutrition and Food Research 2008 52 7 764 771 2-s2.0-53249115785 10.1002/mnfr.200700098
25. Liao F., Li B., Inhibition of shear-induced platelet aggregation by Chinese herbal medicines. Clinical Hemorheology and Microcirculation 1997 17 4 315 318 2-s2.0-0031415595 (Pubitemid 28078071)
26. Bordia A., Effect of garlic on human platelet aggregation in vitro. Atherosclerosis 1978 30 4 355 360 2-s2.0-0018143724 (Pubitemid 9008939)
27. Chung K. F., Mccusker M., Page C. P., Dent G., Guinot P., Barnes P. J., Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man. The Lancet 1987 1 8527 248 251 2-s2.0-0023107863
28. Josic D., Hoffer L., Buchacher A., Preparation of vitamin K-dependent proteins, such as clotting factors II, VII, IX and X and clotting inhibitor Protein C. Journal of Chromatography B 2003 790 1-2 183 197 2-s2.0-0038062927 10.1016/S1570-0232(03)00082-5 (Pubitemid 36588781)
29. Rahimi S., Teymouri Zadeh Z., Karimi Torshizi M. A., Omidbaigi R., Rokni H., Effect of the three herbal extracts on growth performance, immune system, blood factors and intestinal selected bacterial population in broiler chickens. Journal of Agricultural Science and Technology 2011 13 4 527 539 2-s2.0-80052735178
30. Booth S. L., Sadowski J. A., Weihrauch J. L., Ferland G., Vitamin K1 (phylloquinone) content of foods: a provisional table. Journal of Food Composition and Analysis 1993 6 2 109 120 2-s2.0-0001474036 10.1006/jfca.1993. 1014
31. Stafford D. W., The vitamin K cycle. Journal of Thrombosis and Haemostasis 2005 3 8 1873 1878 2-s2.0-28344440666 10.1111/j.1538-7836.2005. 01419.x (Pubitemid 41716574)
32. Preusch P. C., Suttie J. W., Lapachol inhibition of vitamin K epoxide reductase and vitamin K quinone reductase. Archives of Biochemistry and Biophysics 1984 234 2 405 412 2-s2.0-0021688186 (Pubitemid 15189096)
33. Hoult J. R. S., Payá M., Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential. General Pharmacology 1996 27 4 713 722 2-s2.0-0030176193 10.1016/0306-3623(95)02112-4 (Pubitemid 26233347)
34. Shi C.-S., Huang H.-C., Wu H.-L., Kuo C.-H., Chang B.-I., Shiao M.-S., Shi G.-Y., Salvianolic acid B modulates hemostasis properties of human umbilical vein endothelial cells. Thrombosis Research 2007 119 6 769 775 2-s2.0-33947302110 10.1016/j.thromres.2006.06.008 (Pubitemid 46441421)
35. Teng C.-M., Hsueh C.-M., Chang Y.-L., Ko F.-N., Lee S.-S., Liu K. C.-S., Antiplatelet effects of some aporphine and phenanthrene alkaloids in rabbits and man. Journal of Pharmacy and Pharmacology 1997 49 7 706 711 2-s2.0-0030857029 (Pubitemid 27341717)
36. Lambert J.-P., Cormier J., Potential interaction between warfarin and boldo-fenugreek. Pharmacotherapy 2001 21 4 509 512 2-s2.0-0035066596 (Pubitemid 32275282)
37. Williamson E. M., Evans F. J., Cannabinoids in clinical practice. Drugs 2000 60 6 1303 1314 2-s2.0-0034520712 (Pubitemid 32039388)
38. Yamreudeewong W., Wong H. K., Brausch L. M., Pulley K. R., Probable interaction between warfarin and marijuana smoking. Annals of Pharmacotherapy 2009 43 7-8 1347 1353 2-s2.0-67651162228 10.1345/aph.1M064
39. Bland T. M., Haining R. L., Tracy T. S., Callery P. S., CYP2C-catalyzed delta(9)-tetrahydrocannabinol metabolism: Kinetics, pharmacogenetics and interaction with phenytoin. Biochemical Pharmacology 2005 70 7 1096 1103 2-s2.0-24344435153 10.1016/j.bcp.2005.07.007 (Pubitemid 41262085)
40. Williamson E., Driver S., Baxter K., Stockley's Herbal Medicines Interactions 2009 1st London, UK Pharmaceutical Press
41. Budzinski J. W., Foster B. C., Vandenhoek S., Arnason J. T., An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 2000 7 4 273 282 2-s2.0-0033868271 (Pubitemid 30618491)
42. Budzinski J. W., Foster B. C., Vandenhoek S., Arnason J. T., Inhibitory effects of the essential oil of chamomile (Matricaria recutita L.) and its major constituents on human cytochrome P450 enzymes. Life Sciences 2006 78 8 856 861 2-s2.0-30544454307 10.1016/j.lfs.2005.05.095 (Pubitemid 43082310)
43. Maliakal P. P., Wanwimolruk S., Effect of herbal teas on hepatic drug metabolizing enzymes in rats. Journal of Pharmacy and Pharmacology 2001 53 10 1323 1329 2-s2.0-0034758066 10.1211/0022357011777819 (Pubitemid 32982248)
44. Segal R., Pilote L., Research warfarin interaction with Matricaria chamomilla. Canadian Medical Association Journal 2006 174 9 1281 1282 2-s2.0-33646009171 10.1503/cmaj.051191
45. Thanou M., Verhoef J. C., Junginger H. E., Oral drug absorption enhancement by chitosan and its derivatives. Advanced Drug Delivery Reviews 2001 52 2 117 126 2-s2.0-0035813752 10.1016/S0169-409X(01)00231-9 (Pubitemid 33079167)
46. Huang S.-S., Sung S.-H., Chiang C.-E., Chitosan potentiation of warfarin effect. Annals of Pharmacotherapy 2007 41 11 1912 1914 2-s2.0-35748936458 10.1345/aph.1K173 (Pubitemid 350044357)
47. Black J. A., Reduced effect of warfarin caused by ubidecarenone. The Lancet 1993 344 8933 1372 1373 2-s2.0-0028104286 10.1016/S0140-6736(94)90736-6
48. Landbo C., Almdal T. P., Drug interaction between warfarin and coenzym Q10. Ugeskrift for Laeger 1998 160 22 3226 3227 2-s2.0-0032565599 (Pubitemid 28252442)
49. Zhou S., Chan E., Effect of ubidecarenone on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats. Drug Metabolism and Drug Interactions 2001 18 2 99 122 2-s2.0-0035746098 (Pubitemid 34855413)
50. Mousa S. A., Antithrombotic effects of naturally derived products on coagulation and platelet function. Methods in Molecular Biology 2010 663 229 240 2-s2.0-77956081764 10.1007/978-1-60761-803-4-9
51. Greenblatt D. J., von Moltke L. L., Perloff E. S., Luo Y., Harmatz J. S., Zinny M. A., Interaction of flurbiprofen with cranberry juice, grape juice, tea, and fluconazole: in vitro and clinical studies. Clinical Pharmacology and Therapeutics 2006 79 1 125 133 2-s2.0-30444445695 10.1016/j.clpt.2005.09.014 (Pubitemid 43071237)
52. Uesawa Y., Mohri K., Effects of cranberry juice on nifedipine pharmacokinetics in rats. Journal of Pharmacy and Pharmacology 2006 58 8 1067 1072 2-s2.0-33747058281 10.1211/jpp.58.8.0007 (Pubitemid 44213639)
53. Lilja J. J., Backman J. T., Neuvonen P. J., Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam-probes of CYP2C9, CYP1A2, and CYP3A4. Clinical Pharmacology and Therapeutics 2007 81 6 833 839 2-s2.0-34248992947 10.1038/sj.clpt.6100149 (Pubitemid 46788294)
54. Griffiths A. P., Beddall A., Pegler S., Fatal haemopericardium and gastrointestinal haemorrhage due to possible interaction of cranberry juice with warfarin. Journal of The Royal Society for the Promotion of Health 2008 128 6 324 326 2-s2.0-55949135280 10.1177/1466424008096615
55. Rindone J. P., Murphy T. W., Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding. American Journal of Therapeutics 2006 13 3 283 284 2-s2.0-33745853192 10.1097/01.mjt.0000178908. 32892.2f (Pubitemid 44026198)
56. Mohammed Abdul M. I., Jiang X., Williams K. M., Day R. O., Roufogalis B. D., Liauw W. S., Xu H., McLachlan A. J., Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. British Journal of Pharmacology 2008 154 8 1691 1700 2-s2.0-49449094988 10.1038/bjp.2008.210
57. Isele H., Fatal bleeding under warfarin plus cranberry juice-could salicylic acid be the cause? MMW-Fortschritte der Medizin 2004 146 11 13 2-s2.0-1642326568 (Pubitemid 38374370)
58. Committee on Safety of Medicines/Medicines and Healthcare products Regulatory Agency, Interaction between warfarin and cranberry juice: new advice. Current Problems 2004 30 10
59. McGregor G., Fiebich B., Wartenberg A., Brien S., Lewith G., Wegener T., Devil's claw (Harpagophytum procumbens): an anti-inflammatory herb with therapeutic potential. Phytochemistry Reviews 2005 4 1 47 53 2-s2.0-23944465136 10.1007/s11101-004-2374-8 (Pubitemid 41187758)
60. Unger M., Frank A., Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Communications in Mass Spectrometry 2004 18 19 2273 2281 2-s2.0-4644223218 10.1002/rcm.1621 (Pubitemid 39297365)
61. Shaw D., Leon C., Kolev S., Murray V., Traditional remedies and food supplements. Drug Safety 1997 17 5 342 356 2-s2.0-0030700627
62. Hellum B. H., Nilsen O. G., The in vitro inhibitory potential of trade herbal products on human CYP2D6-mediated metabolism and the influence of ethanol. Basic and Clinical Pharmacology and Toxicology 2007 101 5 350 358 2-s2.0-34848906016 10.1111/j.1742-7843.2007.00121.x (Pubitemid 47512382)
63. Hellum B. H., Hu Z., Nilsen O. G., The induction of CYP1A2, CYP2D6 and CYP3A4 by six trade herbal products in cultured primary human hepatocytes. Basic and Clinical Pharmacology and Toxicology 2007 100 1 23 30 2-s2.0-33845996201 10.1111/j.1742-7843.2007.00011.x (Pubitemid 46051439)
64. Gorski J. C., Huang S.-M., Pinto A., Hamman M. A., Hilligoss J. K., Zaheer N. A., Desai M., Miller M., Hall S. D., The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clinical Pharmacology and Therapeutics 2004 75 1 89 100 2-s2.0-1642441388 10.1016/j.clpt.2003.09.013 (Pubitemid 38130121)
65. Gurley B. J., Swain A., Hubbard M. A., Williams D. K., Barone G., Hartsfield F., Tong Y., Carrier D. J., Cheboyina S., Battu S. K., Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea. Molecular Nutrition and Food Research 2008 52 7 755 763 2-s2.0-53249123498 10.1002/mnfr.200600300
66. Abdul M. I. M., Jiang X., Williams K. M., Day R. O., Roufogalis B. D., Liauw W. S., Xu H., Matthias A., Lehmann R. P., McLachlan A. J., Pharmacokinetic and pharmacodynamic interactions of echinacea and policosanol with warfarin in healthy subjects. British Journal of Clinical Pharmacology 2010 69 5 508 515 2-s2.0-77950641040 10.1111/j.1365-2125.2010.03620.x
67. Al-habori M., Raman A., Antidiabetic and hypocholesterolaemic effects of Fenugreek. Phytotherapy Research 1998 12 233 242 (Pubitemid 28331456)
68. Banerjee S. K., Maulik S. K., Effect of garlic on cardiovascular disorders: a review. Nutrition Journal 2002 1, article 1 1 14 2-s2.0-2642540522 10.1186/1475-2891-1-1
69. Foster B. C., Foster M. S., Vandenhoek S., Krantis A., Budzinski J. W., Arnason J. T., Gallicano K. D., Choudri S., An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic. Journal of Pharmacy and Pharmaceutical Sciences 2001 4 2 176 184 2-s2.0-0035735338 (Pubitemid 34305609)
70. Zou L., Harkey M. R., Henderson G. L., Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity. Life Sciences 2002 71 13 1579 1589 2-s2.0-0037119057 10.1016/S0024-3205(02)01913-6 (Pubitemid 34808718)
71. Macan H., Uykimpang R., Alconcel M., Takasu J., Razon R., Amagase H., Niihara Y., Aged garlic extract may be safe for patients on warfarin therapy. Journal of Nutrition 2006 136 3 793 795 2-s2.0-33644847423
72. Shalansky S., Lynd L., Richardson K., Ingaszewski A., Kerr C., Risk of warfarin-related bleeding events and supratherapeutic international normalized ratios associated with complementary and alternative medicine: a longitudinal analysis. Pharmacotherapy 2007 27 9 1237 1247 2-s2.0-34548299671 10.1592/phco.27.9.1237 (Pubitemid 47339121)
73. Rahman K., Billington D., Dietary supplementation with aged garlic extract inhibits ADP-induced platelet aggregation in humans. Journal of Nutrition 2000 130 11 2662 2665 2-s2.0-0033751670
74. Steiner M., Li W., Aged garlic extract, a modulator of cardiovascular risk factors: a dose-finding study on the effects of AGE on platelet functions. Journal of Nutrition 2001 131 3 980 984 2-s2.0-0035119879
75. Gaudineau C., Beckerman R., Welbourn S., Auclair K., Inhibition of human P450 enzymes by multiple constituents of the Ginkgo biloba extract. Biochemical and Biophysical Research Communications 2004 318 4 1072 1078 2-s2.0-2442534164 10.1016/j.bbrc.2004.04.139 (Pubitemid 38625885)
76. von Moltke L. L., Weemhoff J. L., Bedir E., Khan I. A., Harmatz J. S., Goldman P., Greenblatt D. J., Inhibition of human cytochromes P450 by components of Ginkgo biloba. Journal of Pharmacy and Pharmacology 2004 56 8 1039 1044 2-s2.0-4344616168 10.1211/0022357044021 (Pubitemid 39140060)
77. Sugiyama T., Kubota Y., Shinozuka K., Yamada S., Yamada K., Umegaki K., Induction and recovery of hepatic drug metabolizing enzymes in rats treated with Ginkgo biloba extract. Food and Chemical Toxicology 2004 42 6 953 957 2-s2.0-1942534088 10.1016/j.fct.2004.02.007 (Pubitemid 38515779)
78. Etheridge A. S., Black S. R., Patel P. R., So J., Mathews J. M., An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents. Planta Medica 2007 73 8 731 741 2-s2.0-34547730805 10.1055/s-2007-981550 (Pubitemid 47234614)
79. Sugiyama T., Sninozuka K., Sano A., Yamada S., Endoh K., Yamada K., Umegaki K., Effects of various Ginkgo biloba extracts and proanthocyanidin on hepatic cytochrome P450 activity in rats. Food and Chemical Toxicology 2004 42 6 953 957 2-s2.0-17844384550
80. Hellum B. H., Nilsen O. G., In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products. Basic and Clinical Pharmacology and Toxicology 2008 102 5 466 475 2-s2.0-42149119034 10.1111/j.1742-7843.2008.00227.x (Pubitemid 351537792)
81. Engelsen J., Nielsen J. D., Winther K., Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in stable, long-term warfarin treated outpatients. A randomised, double blind, placebo-crossover trial variation in relative risk of venous thromboembolism in different cancers. Thrombosis and Haemostasis 2002 87 6 1075 1076 2-s2.0-0036281554 (Pubitemid 34624893)
82. Jiang X., Williams K. M., Liauw W. S., Ammit A. J., Roufogalis B. D., Duke C. C., Day R. O., McLachlan A. J., Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. British Journal of Clinical Pharmacology 2005 59 4 425 432 2-s2.0-17144396657 10.1111/j.1365-2125.2005.02322.x (Pubitemid 40523886)
83. Matthews M. K., Association of Ginkgo biloba with intracerebral hemorrhage. Neurology 1998 50 6 1933 1934 2-s2.0-0031746009 (Pubitemid 28283304)
84. Vaes L. P. J., Chyka P. A., Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: nature of the evidence. Annals of Pharmacotherapy 2000 34 12 1478 1482 2-s2.0-0033636243
85. Ali B. H., Blunden G., Tanira M. O., Nemmar A., Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food and Chemical Toxicology 2008 46 2 409 420 2-s2.0-37349127807 10.1016/j.fct.2007.09.085 (Pubitemid 350297543)
86. Jiang X., Williams K. M., Liauw W. S., Ammit A. J., Roufogalis B. D., Duke C. C., Day R. O., McLachlan A. J., Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. British Journal of Clinical Pharmacology 2005 59 4 425 432 2-s2.0-17144396657 10.1111/j.1365-2125.2005.02322.x (Pubitemid 40523886)
87. Kuo S.-C., Teng C.-M., Lee J.-C., Ko F.-N., Chen S.-C., Wu T.-S., Antiplatelet components in Panax ginseng. Planta Medica 1990 56 2 164 167 2-s2.0-0025368740 10.1055/s-2006-960916 (Pubitemid 20168046)
88. Janetzky K., Morreale A. P., Probable interaction between warfarin and ginseng. American Journal of Health-System Pharmacy 1997 54 6 692 693 2-s2.0-0031002860 (Pubitemid 27136670)
89. Rosado M. F., Thrombosis of a prosthetic aortic valve disclosing a hazardous interaction between warfarin and a commercial ginseng product. Cardiology 2003 99 2 111 2-s2.0-0037278438 10.1159/000069720 (Pubitemid 36506390)
90. Yuan C.-S., Wei G., Dey L., Karrison T., Nahlik L., Maleckar S., Kasza K., Ang-Lee M., Moss J., Brief communication: American ginseng reduces warfarin's effect in healthy patients. A randomized, controlled trial. Annals of Internal Medicine 2004 141 1 23 27 2-s2.0-3042737049
91. Jiang X., Williams K. M., Liauw W. S., Ammit A. J., Roufogalis B. D., Duke C. C., Day R. O., McLachlan A. J., Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. British Journal of Clinical Pharmacology 2004 57 1 592 599 2-s2.0-3142556133 10.1111/j.1365-2125.2004.02155.x
92. Zhu M., Chan K. W., Ng L. S., Chang Q., Chang S., Li R. C., Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats. Journal of Pharmacy and Pharmacology 1999 51 2 175 180 2-s2.0-0032997935 (Pubitemid 29131310)
93. Bailey D. G., Dresser G. K., Interactions between grapefruit juice and cardiovascular drugs. American Journal of Cardiovascular Drugs 2004 4 5 281 297 2-s2.0-7244224993 10.2165/00129784-200404050-00002 (Pubitemid 39429835)
94. Brandin H., Myrberg O., Rundlöf T., Arvidsson A.-K., Brenning G., Adverse effects by artificial grapefruit seed extract products in patients on warfarin therapy. European Journal of Clinical Pharmacology 2007 63 6 565 570 2-s2.0-34247616082 10.1007/s00228-007-0289-1 (Pubitemid 46684488)
95. Guo L.-Q., Yamazoe Y., Inhibition of cytochrome P450 by furanocoumarins in grapefruit juice and herbal medicines. Acta Pharmacologica Sinica 2004 25 2 129 136 2-s2.0-0442278008 (Pubitemid 38186159)
96. Booth S. L., Madabushi H. T., Davidson K. W., Sadowski J. A., Tea and coffee brews are not dietary sources of vitamin K-1 (phylloquinone). Journal of the American Dietetic Association 1995 95 1 82 83 2-s2.0-0028853443 10.1016/S0002-8223(95)00018-6
97. Taylor J. R., Wilt V. M., Probable antagonism of warfarin by green tea. Annals of Pharmacotherapy 1999 33 4 426 428 2-s2.0-0032953376 10.1345/aph.18238 (Pubitemid 29215809)
98. Parker D. L., Hoffmann T. K., Tucker M. A., Meier D. J., Interaction between warfarin and black tea. Annals of Pharmacotherapy 2009 43 1 150 151 2-s2.0-58549116311 10.1345/aph.1L396
99. Babu P. V. A., Liu D., Green tea catechins and cardiovascular health: an update. Current Medicinal Chemistry 2008 15 18 1840 1850 2-s2.0-52049116999 10.2174/092986708785132979
100. Pleşca-Manea L., Pârvu A. E., Pârvu M., Taamasş M., Buia R., Puia M., Effects of melilotus officinalis on acute inflammation. Phytotherapy Research 2002 16 316 319 (Pubitemid 34700267)
101. Chiffoleau A., Huguenin H., Veyrac G., Argaiz V., Dupe D., Kayser M., Bourin M., Jolliet P., Does melilot interact with acenocoumarol? (melilot-ruscus aculeatus). Therapie 2001 56 3 321 322 2-s2.0-0034968122 (Pubitemid 32554008)
102. Hogan R. P., Hemorrhagic diathesis caused by drinking a herbal tea. Journal of the American Medical Association 1983 249 19 2679 2680 2-s2.0-0020967893 10.1001/jama.249.19.2679 (Pubitemid 13089436)
103. Jakovljevic V., Raskovic A., Popovic M., Sabo J., The effect of celery and parsley juices on pharmacodynamic activity of drugs involving cytochrome P450 in their metabolism. European Journal of Drug Metabolism and Pharmacokinetics 2002 27 3 153 156 2-s2.0-0036656452
104. Bransgrove L. L., Interaction between warfarin and a vitamin K-containing nutritional supplement: a case report. Journal of Herbal Pharmacotherapy 2001 1 1 85 89 2-s2.0-0035114747 10.1300/J157v01n01-07 (Pubitemid 32181584)
105. Hong H., Kim C. S., Maeng S., Effects of pumpkin seed oil and saw palmetto oil in Korean men with symptomatic benign prostatic hyperplasia. Nutrition Research and Practice 2009 3 4 323 327
106. Yue Q.-Y., Jansson K., Herbal drug curbicin and anticoagulant effect with and without warfarin: possibly related to the vitamin E component. Journal of the American Geriatrics Society 2001 49 6 838 2-s2.0-0034941417 (Pubitemid 32652486)
107. Heck A. M., DeWitt B. A., Lukes A. L., Potential interactions between alternative therapies and warfarin. American Journal of Health-System Pharmacy 2000 57 13 1221 1227 2-s2.0-0034235969
108. Friedman J. A., Taylor S. A., McDermott W., Alikhani P., Multifocal and recurrent subarachnoid hemorrhage due to an herbal supplement containing natural coumarins. Neurocritical Care 2007 7 1 76 80 2-s2.0-36949018398 10.1007/s12028-007-0075-z (Pubitemid 350242684)
109. Yale S. H., Glurich I., Analysis of the inhibitory potential of Ginkgo biloba, Echinacea purpurea, and Serenoa repens on the metabolic activity of cytochrome P450 3A4, 2D6, and 2C9. Journal of Alternative and Complementary Medicine 2005 11 3 433 439 2-s2.0-22244480328 10.1089/acm.2005.11.433 (Pubitemid 40994577)
110. Gurley B. J., Gardner S. F., Hubbard M. A., In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto. Clinical Pharmacology and Therapeutics 2005 76 5 428 440 2-s2.0-19344367298 10.1016/j.clpt.2005.03.001 (Pubitemid 40719275)
111. Cheema P., El-Mefty O., Jazieh A. R., Intraoperative haemorrhage associated with the use of extract of saw palmetto herb: a case report and review of literature. Journal of Internal Medicine 2001 250 2 167 169 2-s2.0-0034826031 10.1046/j.1365-2796.2001.00851.x (Pubitemid 32868697)
112. Trock B. J., Leena H.-C., Clarke R., Meta-analysis of soy intake and breast cancer risk. Journal of the National Cancer Institute 2006 98 7 459 471 2-s2.0-33645742060 10.1093/jnci/djj102
113. Foster B. C., Vandenhoek S., Hana J., Krantis A., Akhtar M. H., Bryan M., Budzinski J. W., Ramputh A., Arnason J. T., In vitro inhibition of human cytochrome P450-mediated metabolism of marker substrates by natural products. Phytomedicine 2003 10 4 334 342 2-s2.0-0037911509 10.1078/094471103322004839 (Pubitemid 36597170)
114. Anderson G. D., Rosito G., Mohustsy M. A., Elmer G. W., Drug interaction potential of soy extract and Panax ginseng. Journal of Clinical Pharmacology 2003 43 6 643 648 2-s2.0-0038242508 (Pubitemid 36613123)
115. Cambria-Kiely J. A., Effect of soy milk on warfarin efficacy. Annals of Pharmacotherapy 2002 36 12 1893 1896 2-s2.0-0036894741 (Pubitemid 35429562)
116. Kudo T., Warfarin antagonism of natto and increase in serum vitamin K by intake of natto. Artery 1990 17 4 189 201 2-s2.0-0024991966 (Pubitemid 20300736)
117. Schurgers L. J., Shearer M. J., Hamulyák K., Stöcklin E., Vermeer C., Effect of vitamin K intake on the stability of oral anticoagulant treatment: dose-response relationships in healthy subjects. Blood 2004 104 9 2682 2689 2-s2.0-7244258903 10.1182/blood-2004-04-1525 (Pubitemid 39434948)
118. Pal D., Mitra A. K., MDR- and CYP3A4-mediated drug-herbal interactions. Life Sciences 2006 78 18 2131 2145 2-s2.0-33644891064 10.1016/j.lfs.2005.12.010
119. Gurley B. J., Swain A., Hubbard M. A., Williams D. K., Barone G., Hartsfield F., Tong Y., Carrier D. J., Cheboyina S., Battu S. K., Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea. Molecular Nutrition and Food Research 2008 52 7 755 763 2-s2.0-53249123498 10.1002/mnfr.200600300
120. Bray B. J., Perry N. B., Menkes D. B., Rosengren R. J., St. John's wort extract induces CYP3A and CYP2E1 in the Swiss webster mouse. Toxicological Sciences 2002 66 1 27 33 2-s2.0-0036186534 10.1093/toxsci/66.1.27 (Pubitemid 34202026)
121. Yue Q. Y., Bergquist C., Gerdén B., Safety of St John's wort (Hypericum perforatum). The Lancet 2000 355 9203 576 577 2-s2.0-0034639580
122. Uygur Bayramiçli O., Kalkay M. N., Oskay Bozkaya E., Doan Köse E., Iyigün Ö., Görük M., Sezgin G., St. John's wort (Hypericum perforatum) and warfarin: Dangerous liaisons! Turkish Journal of Gastroenterology 2011 22 1 115 2-s2.0-79953898300 10.4318/tjg.2011.0175
123. Chen X. P., Li W., Xiao X. F., Zhang L. L., Liu C. X., Phytochemical and pharmacological studies on Radix Angelica sinensis. Chinese Journal of Natural Medicines 2013 11 6 577 587
124. Lo A. C. T., Chan K., Yeung J. H. K., Woo K. S., Danggui (Angelica sinensis) affects the pharmacodynamics but not the pharmacokinetics of warfarin in rabbits. European Journal of Drug Metabolism and Pharmacokinetics 1995 20 1 55 60 2-s2.0-0029001650
125. Guo L.-Q., Taniguchi M., Chen Q.-Y., Baba K., Yamazoe Y., Inhibitory potential of herbal medicines on human cytochrome P450-mediated oxidation: properties of Umbelliferous or Citrus crude drugs and their relative prescriptions. Japanese Journal of Pharmacology 2001 85 4 399 408 2-s2.0-0035004474 10.1254/jjp.85.399 (Pubitemid 32421731)
126. Page R. L. II, Lawrence J. D., Potentiation of warfarin by Dong Quai. Pharmacotherapy 1999 19 7 870 876 2-s2.0-0032868436 10.1592/phco.19.10.870.31558 (Pubitemid 29415843)
127. Ellis G. R., Stephens M. R., Minerva. British Medical Journal 1999 319 7210 650 2-s2.0-0033523396 (Pubitemid 29414578)
128. Zhou L., Zuo Z., Chow M. S. S., Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. Journal of Clinical Pharmacology 2005 45 12 1345 1359 2-s2.0-27844511101 10.1177/0091270005282630 (Pubitemid 41643896)
129. Chan K., Lo A. C. T., Yeung J. H. K., Woo K. S., The effects of Danshen (Salvia miltiorrhiza) on warfarin pharmacodynamics and pharmacokinetics of warfarin enantiomers in rats. Journal of Pharmacy and Pharmacology 1995 47 5 402 406 2-s2.0-0029025569
130. Lo A. C. T., Chan K., Yeung J. H. K., Woo K. S., The effects of Danshen (Salvia miltiorrhiza) on pharmacokinetics and pharmacodynamics of warfarin in rats. European Journal of Drug Metabolism and Pharmacokinetics 1992 17 4 257 262 2-s2.0-0027089785 (Pubitemid 23107958)
131. Kuo Y.-H., Lin Y.-L., Don M.-J., Chen R.-M., Ueng Y.-F., Induction of cytochrome P450-dependent monooxygenase by extracts of the medicinal herb Salvia miltiorrhiza. Journal of Pharmacy and Pharmacology 2006 58 4 521 527 2-s2.0-33645564707 10.1211/jpp.58.4.0012
132. Ueng Y.-F., Kuo Y.-H., Peng H.-C., Chen T.-L., Jan W.-C., Guengerich F. P., Lin Y.-L., Diterpene quinone tanshinone IIA selectively inhibits mouse and human cytochrome P4501A2. Xenobiotica 2003 33 6 603 613 2-s2.0-0038772403 10.1080/0049825031000105769 (Pubitemid 36776139)
133. Izzat M. B., Yim A. P. C., El-Zufari M. H., A taste of chinese medicine! Annals of Thoracic Surgery 1998 66 3 941 942 2-s2.0-0032167738 10.1016/S0003-4975(98)00624-9 (Pubitemid 28462137)
134. Tam L. S., Chan T. Y. K., Leung W. K., Critchley J. A. J. H., Warfarin interactions with Chinese traditional medicines: danshen and methyl salicylate medicated oil. Australian and New Zealand Journal of Medicine 1995 25 3 258 2-s2.0-0029101910
135. Qiu F., Wang G., Zhao Y., Sun H., Mao G., A J., Sun J., Effect of danshen extract on pharmacokinetics of theophylline in healthy volunteers. British Journal of Clinical Pharmacology 2008 65 2 270 274 2-s2.0-38849095858 10.1111/j.1365-2125.2007.03027.x (Pubitemid 351192820)
136. Liu J., Wang X., Cai Z., Lee F. S. C., Effect of tanshinone IIA on the noncovalent interaction between warfarin and Human serum albumin studied by electrospray ionization mass spectrometry. Journal of the American Society for Mass Spectrometry 2008 19 10 1568 1575 2-s2.0-53349129384 10.1016/j.jasms.2008. 06.005
137. Potterat O., Goji (Lycium barbarum and L. chinense): phytochemistry, pharmacology and safety in the perspective of traditional uses and recent popularity. Planta Medica 2010 76 1 7 19 2-s2.0-74349093922 10.1055/s-0029- 1186218
138. Lam A. Y., Elmer G. W., Mohutsky M. A., Possible interaction between warfarin and Lycium barbarum L. Annals of Pharmacotherapy 2001 35 10 1199 1201 2-s2.0-0034788447 (Pubitemid 32959186)
139. Rivera C. A., Ferro C. L., Bursua A. J., Gerben B. S., Probable interaction between Lycium barbarum (Goji) and warfarin. Pharmacotherapy 2012 32 3 e50 e53
140. Akbar S., Andrographis paniculata: a review of pharmacological activities and clinical effects. Alternative Medicine Review 2011 16 1 66 77 2-s2.0-79955667793
141. Jarukamjorn K., Don-in K., Makejaruskul C., Laha T., Daodee S., Pearaksa P., Sripanidkulchai B.-O., Impact of Andrographis paniculata crude extract on mouse hepatic cytochrome P450 enzymes. Journal of Ethnopharmacology 2006 105 3 464 467 2-s2.0-33646091746 10.1016/j.jep.2005.11.024
142. Hovhannisyan A. S., Abrahamyan H., Gabrielyan E. S., Panossian A. G., The effect of Kan Jang extract on the pharmacokinetics and pharmacodynamics of warfarin in rats. Phytomedicine 2006 13 5 318 323 2-s2.0-33747104610 10.1016/j.phymed.2005.06.005 (Pubitemid 44382440)
143. Thisoda P., Rangkadilok N., Pholphana N., Worasuttayangkurn L., Ruchirawat S., Satayavivad J., Inhibitory effect of Andrographis paniculata extract and its active diterpenoids on platelet aggregation. European Journal of Pharmacology 2006 553 1-3 39 45 2-s2.0-33751272143 10.1016/j.ejphar.2006.09.052 (Pubitemid 44794498)
144. Iwata H., Tezuka Y., Kadota S., Hiratsuka A., Watabe T., Identification and characterization of potent CYP3A4 inhibitors in Schisandra fruit extract. Drug Metabolism and Disposition 2004 32 12 1351 1358 2-s2.0-9444257635 10.1124/dmd.104.000646 (Pubitemid 39564554)
145. Mu Y., Zhang J., Zhang S., Zhou H.-H., Toma D., Ren S., Huang L., Yaramus M., Baum A., Venkataramanan R., Xie W., Traditional Chinese medicines Wu Wei Zi (Schisandra chinensis Baill) and Gan Cao (Glycyrrhiza uralensis Fisch) activate pregnane X receptor and increase warfarin clearance in rats. Journal of Pharmacology and Experimental Therapeutics 2006 316 3 1369 1377 2-s2.0-33644777715 10.1124/jpet.105.094342 (Pubitemid 43345314)
146. Hye H. Y., Lee M., Min W. L., Sun Y. L., Shin J., Kim D.-H., Effects of Schisandra lignans on P-glycoprotein-mediated drug efflux in human intestinal Caco-2 cells. Planta Medica 2007 73 5 444 450 2-s2.0-34250365825 10.1055/s-2007-967178 (Pubitemid 46917459)
147. Guerra M. C., Speroni E., Broccoli M., Cangini M., Pasini P., Minghetti A., Crespi-Perellino N., Mirasoli M., Cantelli-Forti G., Paolini M., Comparison between Chinese medical herb Pueraria lobata crude extract and its main isoflavone puerarin: Antioxidant properties and effects on rat liver CYP-catalysed drug metabolism. Life Sciences 2000 67 24 2997 3006 2-s2.0-0034602337
148. Zheng J., Chen B., Jiang B., Zeng L., Tang Z.-R., Fan L., Zhou H.-H., The effects of puerarin on CYP2D6 and CYP1A2 activities in vivo. Archives of Pharmacal Research 2010 33 2 243 246 2-s2.0-77949995285 10.1007/s12272-010-0209- 2
149. Liu Q., Lu Z., Wang L., Restrictive effect of puerarin on myocardial infarct area in dogs and its possible mechanism. Journal of Tongji Medical University 2000 20 1 43 45 2-s2.0-0642305219 (Pubitemid 33210417)
150. Heck A. M., DeWitt B. A., Lukes A. L., Potential interactions between alternative therapies and warfarin. American Journal of Health-System Pharmacy 2000 57 13 1221 1227 2-s2.0-0034235969
151. Wang Y. G., Zhou J. M., Ma Z. C., Li H., Liang Q. D., Tan H. L., Xiao C. R., Zhang B. L., Gao Y., Pregnane X receptor mediated-transcription regulation of CYP3A by glycyrrhizin: a possible mechanism for its hepatoprotective property against lithocholic acid-induced injury. Chemico-Biological Interactions 2012 200 11 20
152. Srivastava K. C., Antiplatelet principles from a food spice clove (Syzgium aromaticum L). Prostaglandins Leukotrienes and Essential Fatty Acids 1993 48 5 363 372 2-s2.0-0027273945 10.1016/0952-3278(93)90116-E (Pubitemid 23166512)
153. Saeed S. A., Gilani A. H., Antithrombotic activity of clove oil. Journal of the Pakistan Medical Association 1994 44 5 112 115 2-s2.0-0028289863 (Pubitemid 24190383)
154. Hussain H., Krohn K., Ahmad V. U., Miana G. A., Green I. R., Lapachol: an overview. Arkivoc 2007 2007 2 145 171 2-s2.0-34548266265
155. de la Cruz J. P., Martín-Romero M., Carmona J. A., Villalobos M. A., Sánchez de la Cuesta F., Effect of evening primrose oil on platelet aggregation in rabbits fed an atherogenic diet. Thrombosis Research 1997 87 1 141 149 2-s2.0-0343923476 10.1016/S0049-3848(97)00113-8 (Pubitemid 27333271)
156. Sahler J., Bernard J. J., Spinelli S. L., Blumberg N., Phipps R. P., The Feverfew plant-derived compound, parthenolide enhances platelet production and attenuates platelet activation through NF- B inhibition. Thrombosis Research 2011 127 5 426 434 2-s2.0-79955478936 10.1016/j.thromres.2010.12.013
157. Dam B. H., Glavind J., Vitamin K in the plant. Biochemical Journal 1938 32 2 485 487
158. Franco V., Polanczyk C. A., Clausell N., Rohde L. E., Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols. American Journal of Medicine 2004 116 10 651 656 2-s2.0-2342506587 10.1016/j.amjmed.2003.12.036 (Pubitemid 38581109)
159. Booth S. L., Centurelli M. A., Vitamin K: a practical guide to the dietary management of patients on warfarin. Nutrition Reviews 1999 57 9 288 296 2-s2.0-0032722230 (Pubitemid 29514067)
160. Greenblatt D. J., von Moltke L. L., Perloff E. S., Luo Y., Harmatz J. S., Zinny M. A., Interaction of flurbiprofen with cranberry juice, grape juice, tea, and fluconazole: in vitro and clinical studies. Clinical Pharmacology and Therapeutics 2006 79 1 125 133 2-s2.0-30444445695 10.1016/j.clpt.2005.09.014 (Pubitemid 43071237)
161. Lesho E. P., Saullo L., Udvari-Nagy S., A 76-year-old woman with erratic anticoagulation. Cleveland Clinic Journal of Medicine 2004 71 8 651 656 2-s2.0-4444273203 (Pubitemid 39193340)
162. Vaes L. P. J., Chyka P. A., Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: nature of the evidence. Annals of Pharmacotherapy 2000 34 12 1478 1482 2-s2.0-0033636243
163. Budzinski J. W., Foster B. C., Vandenhoek S., Arnason J. T., Inhibitory effects of the essential oil of chamomile (Matricaria recutita L.) and its major constituents on human cytochrome P450 enzymes. Life Sciences 2006 78 8 856 861 2-s2.0-30544454307 10.1016/j.lfs.2005.05.095 (Pubitemid 43082310)
164. Maliakal P. P., Wanwimolruk S., Effect of herbal teas on hepatic drug metabolizing enzymes in rats. Journal of Pharmacy and Pharmacology 2001 53 10 1323 1329 2-s2.0-0034758066 10.1211/0022357011777819 (Pubitemid 32982248)
165. Yamreudeewong W., Wong H. K., Brausch L. M., Pulley K. R., Probable interaction between warfarin and marijuana smoking. Annals of Pharmacotherapy 2009 43 7-8 1347 1353 2-s2.0-67651162228 10.1345/aph.1M064
166. Bland T. M., Haining R. L., Tracy T. S., Callery P. S., CYP2C-catalyzed delta(9)-tetrahydrocannabinol metabolism: kinetics, pharmacogenetics and interaction with phenytoin. Biochemical Pharmacology 2005 70 7 1096 1103 2-s2.0-24344435153 10.1016/j.bcp.2005.07.007 (Pubitemid 41262085)
167. Foster B. C., Foster M. S., Vandenhoek S., Krantis A., Budzinski J. W., Arnason J. T., Gallicano K. D., Choudri S., An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic. Journal of Pharmacy and Pharmaceutical Sciences 2001 4 2 176 184 2-s2.0-0035735338 (Pubitemid 34305609)
168. Wargovich M. J., Diallyl sulfide and allyl methyl sulfide are uniquely effective among organosulfur compounds in inhibiting CYP2E1 protein in animal models. Journal of Nutrition 2006 136 3 832 834 2-s2.0-33644847036
169. Steiner M., Li W., Aged garlic extract, a modulator of cardiovascular risk factors: a dose-finding study on the effects of AGE on platelet functions. Journal of Nutrition 2001 131 3 980S 984S 2-s2.0-0035119879 (Pubitemid 32194993)
170. Janetzky K., Morreale A. P., Probable interaction between warfarin and ginseng. American Journal of Health-System Pharmacy 1997 54 6 692 693 2-s2.0-0031002860 (Pubitemid 27136670)
171. Gorski J. C., Huang S.-M., Pinto A., Hamman M. A., Hilligoss J. K., Zaheer N. A., Desai M., Miller M., Hall S. D., The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clinical Pharmacology and Therapeutics 2004 75 1 89 100 2-s2.0-1642441388 10.1016/j.clpt.2003.09.013 (Pubitemid 38130121)